WinstonWınston
Back
Galenica AG logo

Galenica AG

GALE.SW
37
Medical - Distribution · Healthcare
Also trades as: 0ROG.L
Price
CHF 81.95
-0.75 (-0.91%)
Market Cap
CHF 4.08B
Exchange
SIX Swiss Exchange
Winston Score
37
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Mixed
Cash Flow
Strong
Stability
Strong
Valuation
Strong
Dividends
Strong

Winston Score History

The full picture

Galenica AG is a Swiss healthcare company that runs one of the largest pharmacy networks in Switzerland. It owns the Amavita, Sun Store, and Coop Vitality pharmacy chains, and it also distributes medicines and healthcare products to pharmacies, hospitals, and doctors across the country. The company sits at the center of Switzerland's pharmaceutical supply chain.

Galenica makes most of its money by buying medicines and health products from manufacturers and selling them to end customers — either directly through its own pharmacies or by wholesaling to independent pharmacies through its Galexis distribution arm. It operates almost entirely within Switzerland, which gives it a stable, regulated market but also limits its growth potential. The main risk is that Swiss healthcare regulations and pricing controls can compress margins, and the company's low gross margin of around 10% leaves little room for error if costs rise or competition from online pharmacies increases.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+7.1% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-24.9% YoY

YoY Growth Rate

Earnings declining

R&D Spend

CHF 8M/ year

Declining (-41% vs prior year)

0.2% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

0.3%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

CHF 333M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Galenica AG is growing revenue at 7% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

+0.5% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 49.6M (2021) → 49.9M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
9.1%
Thin — 9.1% gross margin
Profit after running costs
Operating Margin
3.9%
Thin — 3.9% operating margin
Return on the money invested
ROCE
8.6%
Below par — 8.6% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+6.5%
Slow sales growth (+6.5% YoY)
Profit growth
EPS YoY
-17.4%
Earnings shrinking (-17.4% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
158%
Turns 158% of profit into real cash
Spare cash per sale
FCF Margin
5.1%
Thin free cash flow (5.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.67
Moderate — manageable debt (0.67)
Covers its interest
Interest Cover
13.89x
Comfortably covers interest (13.9x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
25.7x
Growth-priced — P/E 25.7

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+7.2
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (25.7 → 18.4)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.99%
Moderate income — 2.99% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+24.3%
Dividend growing fast (24.3% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial